{"name":"Mage Biologics","slug":"mage-biologics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNeUg5RjV0OTBXMVBNWERuNVpGNnZxMDAzekxadUZST29sbnJoTFRMMHM4V3A3Q2x4ckNfU1pjbTM5U09qNTRlaWRjOEpzUnBqaWhKQkNiMXhYVVQwN3VELWJURlo5YmxSQncxeXIwY0xyVFF1V3hLOE1GTTZ4ZWNGS0YzQmFndHFTQURUeWJOUFhMUEN6bmVkQUM3VWlDQQ?oc=5","date":"2025-07-28","type":"pipeline","source":"Fierce Biotech","summary":"Adaptimmune sells 4 cell therapies to pharma for $55M, plans layoffs - Fierce Biotech","headline":"Adaptimmune sells 4 cell therapies to pharma for $55M, plans layoffs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQR21abEVhQXhnVmtRc1plLUtDa3IxQVUyUk5ZR1Q3SnU1Q0FpenJJOGRHdjJnMUQxSTRBXzZnU0pMbmxHZGhtR1ljNjM2a1pmT1hTTVF3bDN1c1VUb1EtT2ZZUDFzQmMyZ0dqUFgxS1ViR0M4ejJCT1hOZlRDWHRwVDdvX3hQclBzM0dIZHFQMFE1SkY0cHhRRmt0R3lJSFAtM0N5R05vcXNWZGtSTnc5V0NwZHNNeFJVMXZES29CX3o4d190SVVQXzd1VVczYjhaaW1QQWZFVQ?oc=5","date":"2023-07-21","type":"pipeline","source":"BioWorld News","summary":"Mage Biologics receives investment to develop oral monoclonal antibody targeting ulcerative colitis - BioWorld News","headline":"Mage Biologics receives investment to develop oral monoclonal antibody targeting ulcerative colitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQN0dSSTBqSWpZUDVGS0F4dnh3SURuWTVIT0Zmdm12azJGZUZoWk01cG11Mi1KTjVmaHkyWFNyX2NjRF8telo0NnJFQ0xFVkhSZlJlRGxFZU1lYkwwYW1oSk4xa2p2d2ZtQWMxU203ZnltUVdzRWdwbmJpOU1WWnk0MHBwUV9OYzVJczVmWG16ODc?oc=5","date":"2023-07-20","type":"pipeline","source":"Labiotech.eu","summary":"Mage Biologics created to develop oral antibody therapy for ulcerative colitis - Labiotech.eu","headline":"Mage Biologics created to develop oral antibody therapy for ulcerative colitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOdzFlMlZtSFJDQTBDOGh1VExKQWRTQkgybFRMeFZYbVgwQXJwbF82RkJiM1IzdUlfU3ZWMTJsUzBxdzdCY2lMbzFQWnFIY3pGTWxVYlVfM2ZFRElqM1B3aVRsRkxCOHo1OUkxLXNlOS01eVd1NzM2VV9UZHJvUGd4bDBhaDBRVVZraklLZmhwRDNEM0lsbnRfTTBreDJXbk5CZzdfVnRRMC1PRnpPWGRMbGlOcnRPZw?oc=5","date":"2022-05-03","type":"deal","source":"BioWorld News","summary":"Xbiome acquires drug from Assembly Biosciences to treat ulcerative colitis - BioWorld News","headline":"Xbiome acquires drug from Assembly Biosciences to treat ulcerative colitis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}